Dunning A M, Houlston R, Frostegård J, Revill J, Nilsson J, Hamsten A, Talmud P, Humphries S
Arterial Diseases Research Group, Charing Cross Sunley Research Centre, London, U.K.
Biochim Biophys Acta. 1991 Apr 15;1096(3):231-7. doi: 10.1016/0925-4439(91)90010-7.
We have searched for sequence differences in the region of the apolipoprotein B (apo B) gene encoding amino acids 3130-3630 in eight individuals with reduced affinity of low density lipoprotein (LDL) for the normal LDL-receptor. All individuals were hypercholesterolaemic and were selected either on the basis of reduced fractional catabolic rate (FCR) of autologous LDL or substantially reduced binding of their LDL to normal LDL-receptors determined by an in vitro cell growth assay using the U937 macrophage-like cell line. Segments of the apo B gene were amplified by the polymerase chain reaction. Using a combination of cloning and sequencing the amplified fragment, together with chemical cleavage mismatch analysis, no sequence differences were identified in this region of the gene. We therefore conclude that variation outside the region of the apo B gene that codes for amino acids 3130-3630 must be responsible for the reduced LDL clearance in these patients.
我们在八位低密度脂蛋白(LDL)与正常LDL受体亲和力降低的个体中,搜寻了载脂蛋白B(apo B)基因编码氨基酸3130 - 3630区域的序列差异。所有个体均患有高胆固醇血症,他们要么是基于自身LDL的分解代谢率(FCR)降低被挑选出来的,要么是通过使用U937巨噬细胞样细胞系的体外细胞生长试验测定其LDL与正常LDL受体的结合大幅减少而被挑选出来的。apo B基因片段通过聚合酶链反应进行扩增。通过克隆和测序扩增片段的组合,以及化学切割错配分析,在该基因的这个区域未发现序列差异。因此我们得出结论,在apo B基因编码氨基酸3130 - 3630区域之外的变异必定是这些患者LDL清除率降低的原因。